Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Carpenter

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
The Lancet. Rheumatology|January 23, 2024
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guidelineMiriam F Cox, Strachan Mackenzie, Ryan Low, et al.
The Journal of Clinical Investigation|February 28, 2018
Redirection to the bone marrow improves T cell persistence and antitumor functionsAnjum B Khan, Ben Carpenter, Pedro Santos E Sousa, et al.
British Journal of Haematology|November 3, 2017
Transplant results in adults with Fanconi anaemiaMarc Bierings, Carmem Bonfim, Regis Peffault De Latour, et al.
Blood Advances|August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene AutotemcelJosu de la Fuente, Haydar Frangoul, Peter Lang, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Blood Advances|April 6, 2018
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritisJuliana M F Silva, Fani Ladomenou, Ben Carpenter, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Blood|April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMTJuan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
The New England Journal of Medicine|April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Peter Lang, Donna Wall, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
The Lancet. Rheumatology|January 23, 2024
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guidelineMiriam F Cox, Strachan Mackenzie, Ryan Low, et al.
The Journal of Clinical Investigation|February 28, 2018
Redirection to the bone marrow improves T cell persistence and antitumor functionsAnjum B Khan, Ben Carpenter, Pedro Santos E Sousa, et al.
British Journal of Haematology|November 3, 2017
Transplant results in adults with Fanconi anaemiaMarc Bierings, Carmem Bonfim, Regis Peffault De Latour, et al.
Blood Advances|August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene AutotemcelJosu de la Fuente, Haydar Frangoul, Peter Lang, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Blood Advances|April 6, 2018
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritisJuliana M F Silva, Fani Ladomenou, Ben Carpenter, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Blood|April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMTJuan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
The New England Journal of Medicine|April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Peter Lang, Donna Wall, et al.
Pageof 4